3D Systems Corp. (DDD)
NYSEInformation TechnologyComputer HardwareSnapshot 2026-11-05
$1.67-36.74%
Close 2026-11-05 · 1-day change
NYSEInformation TechnologyComputer HardwareSnapshot 2026-11-05
QuarterlyIQ Insights · DDD
How strong the business is — where it ranks within its sector on capital efficiency and cash generation, and how well management has been executing.
How management runs the business: capital, margins, balance sheet, and how reliably they guide and deliver.
A guidance track record builds as the company issues and delivers on guidance.
Priorities management has stated in recent disclosures, with status and evidence drawn from earnings calls, filings, and press releases.
• Net loss was $33.5 million for the quarter, while Adjusted EBITDA improved to $3.1 million, reflecting the benefits of prior cost reduction initiatives, higher sales volumes, and improved operating…
Stated in 2 of 3 supplied quarters. Management reported: “• Net loss was $33.5 million for the quarter, while Adjusted EBITDA improved to $3.1 million, reflecting the benefits of prior cost reduction initiatives, higher sales volumes, and improved operating leverage in the quarter.” “• Amid ongoing global risks, the Company remains focused on building top-line momentum in key markets over the coming quarters, while maintaining disciplined cost management to achieve our goal of full-year break-even Adjusted EBITDA.”
Each factor is a parallel diagnostic with a clear read of what it shows and how names like it have historically fared. Never aggregated into a single score.
Operating income rose in 1 of the last 3 quarter-over-quarter moves. Historically, Information Technology names rated weak grew net income 47% of the time over the next year (vs 59% for the rest of the cohort, n=6380).
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
“• Net loss was $33.5 million for the quarter, while Adjusted EBITDA improved to $3.1 million, reflecting the benefits of prior cost reduction initiatives, higher sales volumes, and improved operating…”
“• Amid ongoing global risks, the Company remains focused on building top-line momentum in key markets over the coming quarters, while maintaining disciplined cost management to achieve our goal of fu…”
• Our four strategic markets delivered strong double-digit growth through the first three quarters of 2026, advancing our strategy to accelerate growth in Med Tech, Dental, Aerospace & Defense and Da…
Stated in 2 of 3 supplied quarters. Management reported: “• Our four strategic markets delivered strong double-digit growth through the first three quarters of 2026, advancing our strategy to accelerate growth in Med Tech, Dental, Aerospace & Defense and Data Center Infrastructure.” “• Q1 2026 revenue of $95.5 million increased 1% year-over-year, or 11% excluding the impact of divestitures, driven by strong performance in the Healthcare business and double‑digit growth across key markets, including Dental, Med Tech, and Aerospace & Defense.”
“• Our four strategic markets delivered strong double-digit growth through the first three quarters of 2026, advancing our strategy to accelerate growth in Med Tech, Dental, Aerospace & Defense and Da…”
“• Q1 2026 revenue of $95.5 million increased 1% year-over-year, or 11% excluding the impact of divestitures, driven by strong performance in the Healthcare business and double‑digit growth across key…”
These results reflect the progress we have made executing a focused strategy: concentrating resources on high-value production applications, refreshing our product portfolio, and expanding our metal…
Stated in 2 of 3 supplied quarters. Management reported: “These results reflect the progress we have made executing a focused strategy: concentrating resources on high-value production applications, refreshing our product portfolio, and expanding our metal parts manufacturing capability.” “• Early success of recently launched products in Dental and Aerospace & Defense markets, including advanced printing systems for monolithic dentures and high‑performance metal components, is expected to support sustained long‑term revenue growth.”
“These results reflect the progress we have made executing a focused strategy: concentrating resources on high-value production applications, refreshing our product portfolio, and expanding our metal…”
“• Early success of recently launched products in Dental and Aerospace & Defense markets, including advanced printing systems for monolithic dentures and high‑performance metal components, is expected…”
Continue cost reduction initiatives and operational efficiency to improve Adjusted EBITDA and reduce operating losses.
Manage capital allocation prudently, including debt maturity planning and cash management.
Over the trailing year it converted 0.22x of net income into operating cash flow.
Most sensitive to the broad stock market.
Not enough signal to read sensitivity to the US dollar, long-term interest rates, real (inflation-adjusted) rates, Fed net liquidity (low R² over the window).
19 material management or governance events in the past 24 months, led by executive changes. Historically, Information Technology names rated volatile grew net income 52% of the time over the next year (vs 57% for the rest of the cohort, n=6008).
Not investment advice. As of 2026-11-05.